CS-834 sankyo

IDrugs

Volumn 2, Issue 3, 1999, Pages 254-258

  Van Ogtrop, M L ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

6 (1 HYDROXYETHYL) 4 METHYL 7 OXO 3 (5 OXO 3 PYRROLIDINYLTHIO) 1 AZABICYCLO[3.2.0]HEPT 2 ENE 2 CARBOXYLIC ACID; 6 (1 HYDROXYETHYL) 4 METHYL 7 OXO 3 (5 OXO 3 PYRROLIDINYLTHIO) 1 AZABICYCLO[3.2.0]HEPT 2 ENE 2 CARBOXYLIC ACID PIVALOYLOXYMETHYL ESTER; BETA LACTAM ANTIBIOTIC; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; CLINICAL TRIAL; DIARRHEA; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG STRUCTURE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; SHORT SURVEY;

EID: 0032966482     PISSN: 13697056     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. 12924 In vitro and in vivo antibacterial activity of KY-109, a new orally active cephalosporin. Obana Y, Hashizume H, Yoshimi A, Nishino T J ANT1BIOT1988 41 949-958
2. 215555 New drugs in the R & D pipeline. PHARMA JPN1996 1510 17-18
3. 220240 36th ICAAC, New Orleans September 15-18 IDDB MEETING RÉPORT 1996 September, 15-18
4. 220283 CS-834, a new oral carbapenem: I. Structure activity relationships of 2-substituted 1-beta-methylcarbapenems. Kawamoto I, Miyauchi M, Endo R, Hisaoka M. Yasuda H, Kuwahara S ICAAC1996 36th New Orleans Abs F105
5. 220285 CS 834, a new oral carbapenem: II. In vitro evaluation of R-95867, the active metabolite of CS-834. Utsui Y, Takenouchi T, Masuda N, Domon H, Kakuta M, Ishii C, Sakagawa E, Abe T, Ohyo S, Yasuda H. Iwata M, Kuwahara S ICAAC 1996 36th New Orleans Abs F106
6. 20287 CS-834, a new oral carbapenem: III. In vivo evaluation of CS-S34. Ohyo S, Fukuoka T, Koga T, Takenouchi T. Kawada H, Yasuda H, Iwata M, Kuwahara S, Sakagawa E, Kubota M ICAAC 1996 36th New Orleans Abs F107
7. 220288 CS-834, a new oral carbapenem: IV. Pharmacokinetics, metabolism and safety In laboratory animals. Nakagawa A, Shigeta A, Watanabe N, Muramatsu S, Naganuma H, Kunisada K, Hisaoka M, Manabe S, Kuwahara SICAAC1996 36th New Orleans Abs F108
8. 220289 CS-834, a new oral carbapenem: V. Safety and pharmacoknetics In healthy male volunteers. Nakashima M, Umemura K, Ikeda Y, Kondou K ICAAC 1996 36th New Orleans Abs F109
9. 225841 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans, Louisiana, USA, September 15 -18,1996 Barrett JF, Macielag MJ, Femandez J, Hlasts DJ EXP OP1N INVEST DRUGS 1996 5 11 1533-1548
10. 243477 In vitro and in vivo antibacterial activities of ER-35786, a new antipseudomonal carbapenem. Ohba F, Nakamura Kamijo ' M. Watanabe NA, Katsu K ANTIM1CROB AGENTS CHEMOTHER 1997412298-307
11. 255861 Synthesis and structure-activity relationships of novel oral carbapenem, CS-834. Miyauchi M, Endo R, Hisaoka M, Yasuda H, Kawamoto l J/W778/O71997 50 5 429-439
12. 261531 New drugs in the R&D pipeline: Sankyo. PHARMA JPN 19971563 22
13. 265280 Interscience Conference on Antimicrobial Agents and Chemotherapy. 37th Annual Meeting (Part II), Poster Session, Toronto, Ontario, Canada IDDB MEETING REPORT 1997 Sept 28-Oct 1
14. 267354 Sankyo, Glaxo Wellcome launch Troglitazone in UK. PHARMA JPN 19971570 5
15. 267892 In vitro activity of CS-834 a new oral carbapenem.against anaerobic bacteria. Kato N, Tanaka-Bandoh K, Kato H, Watanabe K ICAAC 1997 37th Toronto F-206
16. 267894 In vitro and in vivo antibacterial activity of CS-834 a new oral carbapenem comparison with fluoroquinolones. Ohya S, Utsui Y, Domon H,-'Fukuoka T, Koga T, Masuda N, Kawada H, Kubota M, kitayama A, Kamai T, Harasaki C, Yasuda h ICAAC 1997 37th Toronto F-207
17. 267896 A New oral carbapenim in vitro antibacterial activity against clinical isolates including various types of lactamase producers. Kuga A, Sato Y, Okamoto R, [noue M ICAAC 1997 37th Toronto F-208
18. 267900 CS-834 A new oral carbapenem in vitro antibacterial activity against clinical isoloates Including methicillin-resistant Staphyloccus aureus. Hanake H, Konko N ICAAC 1997 37th Toronto F-209.
19. 267901 Comparative antibacterial activity of CS-834 with imipenim and other lactam antibiotics against clinical isolates clinical isolates from otitis media pneumonia and respiratory tract Infections. Ubukata K, Muraki T, igarashi A, Asahi Y, Konno M ICAAC 1997 37th Toronto F-210
20. 267903 CS-834 A new oral carbapenem in vitro and in vivo antibacterial activity effect on bacterial morphology and affinity for penicllin-binding proteins. Nishimo T, Sakagawa E, Otsuki M ICAAC 1997 37th Toronto F-211
21. 267905 In vitro and in vivo antibacterial activity of CS-834 a New oral carbapenem. Miyazaki S, Domon H, Ishii Y, Matsumoto T, Tateda K, Yamaguchi K ICAAC 1997 37th Toronto F-212
22. 267906 In vitro antibacterial activity of S-4661 against clinical isolates organisms. Yamaguche K, Shimada Z ICAAC 1997 37th Toronto F-213
23. 267908 Effect of alterations in porins and efflux pumps of Pseudomonas aeruginosa on the in vitro antipseudomonal activity of S-4661. Yamano Y, Nishikawa T. Komatsu Y ICAAC 1997 37th Toronto F-214
24. 267910 Carbapenem-induced resistance in Pseudomonas aeruginosa clinical stains to carbapenems including S4661 meropenem and imipenem. Sakyo S, Tanimoto K, Fujimoto S, Yasuyoshi I ICAAC 1997 37th Toronto F-215
25. 267911 Synergy with S-4661 and vancomycin or teicoplanin against imipenem-resistant MRSA identified by the PCR method. ICAAC 1997 37th Toronto F-216
26. 267917 Pharmacokinetics and Pharmacodynamics of S-4661 New parenteral carbapenem antibiotic. Shiba K, Makashima M, Tanimura H, Okada H, Shimada J ICAAC 1997 37th Toronto F-217
27. 267918 Clinical studies of S-4661 new parenteral carbapenem antibiotic in complicated urinary tract infections. Arakawa S, Kamidono S, Inamatsu T. Shimada J ICAAC 1997 37th Toronto F-218
28. 267919 Clinical studies of S-4661 New parenteral carbapenem antibiotic in chronic respiratory tract infections. Saito A, Inamatsu T, Shimada J ICAAC 1997 37th Toronto F-219
29. 267922 S-4661 a new carbapenem has weak convulsant activity. A comparative study on convulsant activity of carbapenems and cepalosporins. Hori S, Sato J, Kawamura M, Shimada J ICAAC 1997 37th Toronto F-220
30. 271372 Troglitazone to follow pravastatin as global strategic product/Mr Kurebayashi of Sankyo. PHARMA JPN199715761-3
31. 271854 37th Interscience conference on antimicrobial agents and chemotherapy (ICAAC). Frosco M, Lawrence LE, Barrett JF EXP OPIN INVEST DRUGS-1997 6 121951-1968
32. 275435 Sankyo's imitrodast nearing market SCRIP 1998230018
33. 277513 Analyst report - antibiotic therapeutic review. Codetta A, Brewer M, Beadle D, Brinde S ANALYST REPORT 1998 February
34. 289060 In vitro and in vivo antibacterial activities of CS-834, a new oral carbapenem. Yamaguchi K, Domon H, Miyazaki S, Tateda K, Ohno A, Ishii K, Matsumoto T, Furuya N ANT1MICROB AGENTS CHEMOTHER1998 3 42 555-563
35. 292267 A novel oral carbapenem CS-834: chemical stability of pivaloyloxymethy! esters of carbapenems and cephalosporins in phosphate buffer solution [letter]. Miyauchi M, Kanno O, Kawamoto I J>W77B/Ori997 50 9 794-796
36. 292269 Safety and pharmacokinetics of CS-834, a new oral carbapenem antibiotic, in healthy volunteers. Umemura K, Ikeda Y, Kondo K, Nakashima M, Naganuma H, Hisaoka M, Nishino H, Tajima M ANTIMICROB AGENTS CHEMOTHER 1997 41 122664-2669
37. 292271 CS-834, a new oral carbapenem: V. Safety and pharmacokinetics in healthy male volunteers. Nakashima M, Umemura K, Ikeda Y, Kondou K, Naganuma H, Utsui Y ICAAC 1996 36th New Orleans 119
38. 292273 CS-834, a new oral carbapenem: II. In vitro evaluation of R95867, the active metabolite of CS-834. Utsui Y, Takenouchi T, Masuda N, Domon H, Kakuta M, Ishii C, Ishii C, et al ICAAC 1996 36th New Orleans 118
39. 292274 CS-834, a new oral carbapenem: I. Structure-activity relationships of 2-substituted 1-beta-methylcarbapenems. Kawamoto I, Miyauchi M, Endo R, Hisaoka M, Yasuda H, Kuwahara S 1CAAC1996 36th New Orleans 118 i Structure-activity relationship of 2-substituted 1-beta-methyl carbapenems.
40. 292275 CS-834, a new oral carbapenem: IV. Pharmacokinetics, metabolism and safety In laboratory animals. Nakagawa A, Shigeta A, Watanabe N, Muramatsu S, Naganuma H, Kunisada K, Hisaoka M. Manabe S, Kuwahara S ICAAC1996 36th New Orleans 118
41. 292276 CS-634, a new oral carbapenem: III. In vivo evaluation of CS-634. Ohya S, Fukuoka T, Koga T, Takenouchi T, Kawada H, Harasaki T, Hirasawa A, Ishii C, Sakagawa E, Kubota M, Yasuda H, et al ICAAC 1996 36th New Orleans 118
42. 293927 In vitro and In vivo antibacterial activities of CS-834, a novel oral carbapenem. Fukuoka T, Ohya S, Utsui Y, Domon H, Takenouchi T, Koga T, Masuda N, Kawada H, Kakuta M, Kubota M, Ishii C et al ANTIMICROB AGENTS CHEMOTHER 1997 41 26522663
43. 295576 New approaches and agents to overcome bacterial resistance. Domagala JM, Sanchez JP ANN REP MEDICINAL CHEM, BristolJA (ED). 199732 111-120
44. 297975 In vitro and in vivo antibacterial activities of CS-834, a new oral carbapenem. Yamaguchi K, Domon H, Miyazaki S, Taleda K, Ohno A, Ishii K, Matsumoto T, Furuya N ANTIMICROB AGENTS CHEMOTHER 1998 42 3 555-563
45. 302380 SANKYO: Annual Report 1997. Sankyo Co Ltd ANNUAL REPORT-\997
46. 307200 In vivo antimicrobial activity of CS-834, a novel oral carbapencm, against various penicillin-resistant pneumococci. Van Ortrop ML, Andes D, Craig WA ICAAC1998 38 San Diego F-49
47. 307202 In vivo pharmacodynamic activity of CS-834, a new oral carbapencm. Van Ogtrop ML, Andes D, Craig WA ICAAC 1998 38 San Diego F-50
48. 307205 A multiple dose-ascending pharmacokinetic study of a new orally active antibiotic prodrug CS-834 in healthy adult volunteers. Stevens RE, Konsil J, Silletti SL, Wason S, Gonzalez L, Schwocho LR ICAAC 1998 38 San Diego F-51
49. 307206 In vitro bacterial activity of CS-834, a new oral carbapenem, with its stimulated human plasma concentrations. Utsui Y, Ishi C, Domon H, Abe T, Kakula M, Sakagawa E, Ishi C, Masuda N, Ohya S, Kuwahara S ICAAC 1998 38 San Diego F-58
50. 307208 Therapeutic efficacy of CS-834, a new oral carbapenem, against murine pneumonia caused by penicillin-susceptible and -resistant Streptococcus pneumoniae. Ohya S, Kawada H, Fukuoka T, Koga T, Kitayama A, Yasuda H, Kuwahara S ICAAC 1998 38 San Diego F-59
51. 307211 The in vitro activity of CS-834, a new orally available carbapenem. Schwocho LR, Hickey M, Sahm DF, Thomsberry C ICAAC 1998 38 San Diego F71
52. 308983 Efficacy of CS-834 against experimental pneumonia caused by penicillin-susceptible and -resistant Streptococcus pneumoniae in mice. Fukuoka T, Kawada H, Kitayama A, Koga T, Kubota M, Harasaki T, Kama! Y, Ohya S, Yasuda H, Iwata M, Kuwahara S ANTIMICROB AGENTS CHEMOTHER1998 42 23-27